| Nov 5 |
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
|
| Nov 2 |
Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)
|
| Nov 1 |
Galapagos NV (GLPG) Q3 2024 Earnings Call Highlights: Strong Cash Position and R&D Progress ...
|
| Oct 31 |
Galapagos NV 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 31 |
Galapagos NV (GLPG) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Galapagos reports 9M results
|
| Oct 30 |
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Oct 29 |
Galapagos Q3 2024 Earnings Preview
|
| Oct 7 |
Galapagos grants an investor a seat on its board
|
| Oct 7 |
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
|
